Guardian Pharmacy Services, Inc.

Listed Company

GRDNCIK 0001802255NYSEAcceleratedRetail-Drug Stores And Proprietary StoresGeorgiaFY ends Dec 31

Period

FY 2025

Revenue

$1.45B

Net Income

$49.22M

Total Assets

$412.66M

Equity

$217.92M

Shares Out

—

Op. Cash Flow

$100.25M

Business

Guardian Pharmacy Services, Inc. is a pharmacy services company that delivers technology-enabled, high-touch pharmacy care to residents of long-term care facilities. It offers customized dispensing and compliance packaging, automated robotic dispensing, EMAR integration, clinical pharmacist medication reviews, formulary coordination, caregiver training, and proprietary data analytics and reporting. Guardian’s operations are organized around serving assisted living facilities and behavioral health facilities/group homes as core target segments while also serving skilled nursing facilities through locally operated pharmacies supported by centralized corporate services (GuardianCompass/GuardianShield). The company operates a network of local pharmacies that deliver daily to LTCFs across multiple U.S. states and provide 24/7 on-call pharmacist and logistics support.

Summary from filing dated 2025-03-26

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Revenues	1,449	1,228	1,046
Cost of goods sold	1,156	984	838
Gross profit	293	244	208
Selling, general, and administrative expenses	220	307	167
Operating income (loss)	73	−63	41
Interest expense	665,000	3	3
Other expense (income), net	−1	279,000	367,000
Total other expenses (income)	−722,000	4	3
Income (loss) before income taxes	73	−66	38
Provision for income taxes	24	5	0
Net income (loss)	49	−71	38
Less net income attributable to Guardian Pharmacy, LLC prior to the Corporate Reorganization	0	23	24
Less net income (loss) attributable to non-controlling interests	−261,000	16	14
Net income (loss) attributable to Guardian Pharmacy Services, Inc.	49	−110	—

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Cash and cash equivalents	66	5	752,000	—
Accounts receivable, net	102	97	77	—
Inventories	43	41	37	—
Other current assets	11	10	15	—
Total current assets	222	152	130	—
Property and equipment, net	56	50	45	—
Intangible assets, net	18	15	12	—
Goodwill	80	69	56	—
Operating lease right-of-use assets	35	29	28	—
Deferred tax assets	2	5	0	—
Other assets	436,000	383,000	358,000	—
Total assets	413	321	271	—
Accounts payable	116	102	86	—
Accrued compensation	15	14	17	—
Operating leases, current portion	7	7	6	—
Other current liabilities	22	20	16	—
Total current liabilities	161	144	138	—
Operating leases, net of current portion	30	23	23	—
Other liabilities	4	3	31	—
Total liabilities	195	171	211	—
Commitments and contingencies (see Note 6)	—	—	—	—
Members' equity	0	0	—	—
Additional paid-in capital	139	125	—	—
Retained earnings	66	17	—	—
Non-controlling interests	12	7	32	—
Total equity	218	150	60	76
Total liabilities and equity	413	321	271	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Net income (loss)	49	−71	38
Depreciation and amortization	22	20	18
Share-based compensation expense	14	131	−6
Provision for losses on accounts receivable	5	6	5
Change in deferred tax asset	3	0	—
Other	1	767,000	283,000
Accounts receivable	−9	−25	−14
Inventories	−877,000	−1	4
Other current assets	−2	−2	−5
Accounts payable	16	13	6
Accrued compensation	618,000	−3	3
Other operating liabilities	1	−11	21
Net cash provided by operating activities	100	58	71
Purchases of property and equipment	−20	−16	−15
Payment for acquisitions	−13	−15	−985,000
Other	736,000	671,000	2
Net cash used in investing activities	−32	−30	−13
Proceeds from equity offering, net of underwriter fees	29	120	—
Payments of equity offering costs	−2	−4	—
Borrowings from notes payable	0	15	—
Repayment of notes payable	−497,000	−38	−4
Borrowings from line of credit	0	189	270
Repayments of line of credit	0	−198	−265
Principal payments on finance lease obligations	−4	−4	−4
Payments related to acquisitions	−3	0	−325,000
Contributions from non-controlling interests	2	3	889,000
Distributions to non-controlling interests	−458,000	−14	−16
Member distributions	0	−36	−38
Other	500,000	−160,000	—
Net cash used in financing activities	−7	−24	−57
Net change in cash and cash equivalents	61	4	145,000
Cash paid during the year for interest	650,000	3	3
Cash paid during the year for income taxes	22	0	—
Purchases of property and equipment through finance leases	5	4	6
Accrued and capitalized offering costs recorded to additional paid-in capital	0	9	—
Non-cash equity contributions from non-controlling members	4	6	0

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro